Schedule 13D ownership disclosure
BIOLINERX LTD
Security class unavailable · CUSIP: 09071M205
Event date: 2023-10-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 102,437,055
- Percent of class
- 9.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-23-003401
- Form type
- SC 13D
- Filer
- BioLineRx Ltd.
- CIK
- CIK 1498403
- Filed
- Oct 26, 2023
- Reporting period
- Oct 09, 2023
- Description
- Schedule 13D beneficial ownership